Preclinical studies generally suffer from a lack of consistency and replication.

Preclinical data is inconclusive regarding optimal cell type/manipulation for clinical trials.

Use of improper controls and inappropriate statistics prevents interpretation of many studies.

Future clinical trials should release negative results to the SCI research field.